Jillian Dilmore - 16 Apr 2022 Form 3 Insider Report for Baudax Bio, Inc. (BXRX)

Role
Corporate Controller/Secretary, PFO and PAO
Signature
/s/ Gerri Henwood, Attorney-in-fact
Issuer symbol
BXRX
Transactions as of
16 Apr 2022
Transactions value $
$0
Form type
3
Filing time
26 Apr 2022, 16:21:13 UTC
Next filing
17 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BXRX Common Stock 171 16 Apr 2022 Direct F1
holding BXRX Common Stock 67 16 Apr 2022 Direct F2
holding BXRX Common Stock 25 16 Apr 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BXRX Stock Option (right to buy) 16 Apr 2022 Common Stock 257 $221.55 Direct F3
holding BXRX Stock Option (right to buy) 16 Apr 2022 Common Stock 162 $39.2 Direct F4
holding BXRX Stock Option (right to buy) 16 Apr 2022 Common Stock 313 $45.5 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of 171 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock of Baudax Bio, Inc. (the "Company"). The restricted stock units vest annually in four equal installments commencing on December 5, 2020, subject to continued service to the Company on the applicable vesting dates. The restricted stock units will be settled on the applicable vesting dates in shares of the Company's common stock.
F2 Consists of 67 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock of the Company. The restricted stock units vest annually in four equal installments commencing on January 15, 2022, subject to continued service to the Company on the applicable vesting dates. The restricted stock units will be settled on the applicable vesting dates in shares of the Company's common stock.
F3 The stock option vests in equal monthly installments over 48 months, beginning on January 5, 2020, subject to continued service to the Company on the applicable vesting dates.
F4 The stock option vested in two equal, semi-annual installments on June 30, 2021 and December 31, 2021.
F5 The stock option vests in equal monthly installments over 48 months, beginning on February 15, 2021, subject to continued service to the Company on the applicable vesting dates.